ChemoMetec Forecast, price target & analysts
ChemoMetec Target price 2025 - Analyst rating & recommendation
ChemoMetec Classifications & Recommendation:
ChemoMetec Price Target
| Target Price | DKK652.80 |
| Price | DKK568.50 |
| Potential |
14.83%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target ChemoMetec 2026 .
The average ChemoMetec target price is DKK652.80.
This is
14.83%
register free of charge
DKK672.00
18.21%
register free of charge
DKK520.15
8.50%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend ChemoMetec to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ChemoMetec stock has an average upside potential 2026 of
14.83%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million DKK | 407.87 | 510.37 |
| 8.22% | 25.13% | |
| EBITDA Margin | 45.65% | 56.91% |
| 19.19% | 24.67% | |
| Net Margin | 33.41% | 40.24% |
| 16.89% | 20.43% |
5 Analysts have issued a sales forecast ChemoMetec 2025 . The average ChemoMetec sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an ChemoMetec EBITDA forecast 2025. The average ChemoMetec EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 ChemoMetec Analysts have issued a net profit forecast 2025. The average ChemoMetec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share DKK | 7.83 | 11.80 |
| 23.76% | 50.70% | |
| P/E | 48.16 | |
| EV/Sales | 18.13 |
5 Analysts have issued a ChemoMetec forecast for earnings per share. The average ChemoMetec EPS is
This results in the following potential growth metrics and future valuations:
Current ChemoMetec Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Nov 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Feb 05 2025 |
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Nov 10 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
